Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Elafin

EU orphan designation number: EU/3/07/443   
Active ingredient: Elafin
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Proteo Biotech AG
Am Kiel Kanal 44, 24106 Kiel, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2007 Orphan designation EMEA/OD/088/06 (2007)1326 of 20/03/2007